Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus

Anticancer research

Volumn 36, Issue 2, 2016, Pages 829-834

  Ojima, Toshiyasu ^a   Nakamori, Mikihito ^a   Nakamura, Masaki ^a   Katsuda, Masahiro ^a   Hayata, Keiji ^a   Kato, Tomoya ^a   Kitadani, Junya ^a   Tabata, Hirotaka ^a   Takeuchi, Akihiro ^a   Iwahashi, Makoto ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

cisplatin; docetaxel; Esophageal cancer; fluorouracil; neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL; TAXOID;

ADJUVANT CHEMOTHERAPY; AGED; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; NEOADJUVANT THERAPY; NEUTROPENIA; PATHOLOGY; PHASE 2 CLINICAL TRIAL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUTROPENIA; RISK FACTORS; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84979841872     PISSN: None     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (0)